HIT Valuation

Health In Tech Inc

Add to Watchlist

Advanced Chart

3.050

-0.19(-5.864%)1D

Overview
Forecast
Valuation
Earnings

HIT Relative Valuation

HIT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HIT is overvalued; if below, it's undervalued.

Historical Valuation

Health In Tech Inc (HIT) is now in the Fair zone, suggesting that its current forward PE ratio of 22.59 is considered Fairly compared with the five-year average of 14.90. The fair price of Health In Tech Inc (HIT) is between 0.53 to 3.21 according to relative valuation methord.

Relative Value

Fair Zone

0.53-3.21

Current Price：3.05

Fair

22.59

Trailing

Forward

23.41

EV/EBITDA

Health In Tech Inc. (HIT) has a current EV/EBITDA of 23.41. The 5-year average EV/EBITDA is 4.80. The thresholds are as follows: Strongly Undervalued below -10.22, Undervalued between -10.22 and -2.71, Fairly Valued between 12.31 and -2.71, Overvalued between 12.31 and 19.83, and Strongly Overvalued above 19.83. The current Forward EV/EBITDA of 23.41 falls within the Strongly Overvalued range.

40.87

EV/EBIT

Health In Tech Inc. (HIT) has a current EV/EBIT of 40.87. The 5-year average EV/EBIT is 11.15. The thresholds are as follows: Strongly Undervalued below -22.87, Undervalued between -22.87 and -5.86, Fairly Valued between 28.15 and -5.86, Overvalued between 28.15 and 45.16, and Strongly Overvalued above 45.16. The current Forward EV/EBIT of 40.87 falls within the Overvalued range.

4.31

Health In Tech Inc. (HIT) has a current PS of 4.31. The 5-year average PS is 1.38. The thresholds are as follows: Strongly Undervalued below -1.01, Undervalued between -1.01 and 0.18, Fairly Valued between 2.57 and 0.18, Overvalued between 2.57 and 3.76, and Strongly Overvalued above 3.76. The current Forward PS of 4.31 falls within the Strongly Overvalued range.

35.61

P/OCF

Health In Tech Inc. (HIT) has a current P/OCF of 35.61. The 5-year average P/OCF is 6.99. The thresholds are as follows: Strongly Undervalued below -15.59, Undervalued between -15.59 and -4.30, Fairly Valued between 18.29 and -4.30, Overvalued between 18.29 and 29.58, and Strongly Overvalued above 29.58. The current Forward P/OCF of 35.61 falls within the Strongly Overvalued range.

85.75

P/FCF

Health In Tech Inc. (HIT) has a current P/FCF of 85.75. The 5-year average P/FCF is 18.68. The thresholds are as follows: Strongly Undervalued below -38.04, Undervalued between -38.04 and -9.68, Fairly Valued between 47.04 and -9.68, Overvalued between 47.04 and 75.41, and Strongly Overvalued above 75.41. The current Forward P/FCF of 85.75 falls within the Strongly Overvalued range.

Health In Tech Inc (HIT) has a current Price-to-Book (P/B) ratio of 10.47. Compared to its 3-year average P/B ratio of 12.82 , the current P/B ratio is approximately -18.35% higher. Relative to its 5-year average P/B ratio of 12.82, the current P/B ratio is about -18.35% higher. Health In Tech Inc (HIT) has a Forward Free Cash Flow (FCF) yield of approximately 1.97%. Compared to its 3-year average FCF yield of 5.50%, the current FCF yield is approximately -64.18% lower. Relative to its 5-year average FCF yield of 5.50% , the current FCF yield is about -64.18% lower.

10.47

P/B

Median3y

12.82

Median5y

12.82

1.97

FCF Yield

Median3y

5.50

Median5y

5.50

Competitors Valuation Multiple

The average P/S ratio for HIT's competitors is 4.04, providing a benchmark for relative valuation. Health In Tech Inc Corp (HIT) exhibits a P/S ratio of 4.31, which is 6.82% above the industry average. Given its robust revenue growth of 86.18%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

HUHUTECH International Group Inc

Performance Decomposition

Market capitalization of HIT decreased by 44.75% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 5.00M to 9.31M.

The secondary factor is the Margin Expansion, contributed 0.15%to the performance.

Overall, the performance of HIT in the past 1 year is driven by Revenue Growth. Which is more sustainable.

86.18%

5.00M → 9.31M

Revenue Growth

0.15%

6.76 → 6.77

Margin Expansion

-131.08%

-476.54 → 148.11

P/E Change

-44.75%